BACKGROUND	End-stage renal disease and the need for chronic hemodialysis is an indication for hepatitis B vaccination , but up to half of dialysis patients fail to respond to a 40 microg/dose i.m. three-dose primary series of recombinant hepatitis B vaccine .\